XML 30 R21.htm IDEA: XBRL DOCUMENT v3.10.0.1
Segment Information (Tables)
6 Months Ended
Jun. 30, 2018
Segment Reporting [Abstract]  
Schedule of segment results of operations

 

b.The following presents segment results of operations for the six months ended June 30, 2018 (unaudited):

 

     Cellocator segment  

MRM

segment

   Elimination   Total 
                   
  Segments revenues  $12,729   $32,304   $(4,410)  $40,623 
                       
  Segments operating profit   1,201    4,405    (281)   5,325 
                       
  Segments tangible and intangible assets   8,751    35,144    1,557    45,452 
                       
  Depreciation and amortization   86    1,259    -    1,345 
                       
  Expenditures for assets   82    1,551    -    1,633 

 

c.The following presents segment results of operations for the six months ended June 30, 2017 (unaudited):

 

     Cellocator segment  

MRM

segment

   Elimination   Total 
                   
  Segments revenues  $12,535   $30,502   $(3,965)  $39,072 
                       
  Segments operating profit   1,150    3,471    469    5,090 
                       
  Segments tangible and intangible assets   8,943    37,403    2,104    48,450 
                       
  Depreciation and amortization   67    1,384    -    1,451 
                       
  Expenditures for assets   102    1,010    -    1,112 

 

d.The following presents segment results of operations for the three months ended June 30, 2018 (unaudited):

 

     Cellocator segment  

MRM

segment

   Elimination   Total 
                   
  Segments revenues  $6,159   $15,593   $(2,012)  $19,740 
                       
  Segments operating profit   492    2,380    (114)   2,758 
                       
  Segments tangible and intangible assets   8,751    35,144    1,557    45,452 
                       
  Depreciation and amortization   43    584    -    627 
                       
  Expenditures for assets   39    635    -    674 

 

e.The following presents segment results of operations for the three months ended June 30, 2017 (unaudited):

 

     Cellocator segment  

MRM

segment

   Elimination   Total 
                   
  Segments revenues  $6,383   $15,576   $(1,918)  $20,041 
                       
  Segments operating profit   699    1,798    337    2,834 
                       
  Segments tangible and intangible assets   8,943    37,403    2,104    48,450 
                       
  Depreciation and amortization   34    567    -    601 
                       
  Expenditures for assets   44    300    -    344 

 

f.The following presents segment results of operations for the year ended December 31, 2017:

 

     Cellocator segment  

MRM

segment

   Elimination   Total 
                   
  Segments revenues  $24,364   $62,208   $(8,417)  $78,155 
                       
  Segments operating profit   2,742    7,569    (2)   10,309 
                       
  Segments tangible and intangible assets   9,026    37,799    1,968    48,793 
                       
  Depreciation, amortization and impairment expenses   144    2,780    -    2,924 
                       
  Expenditures for assets   197    3,069    -    3,266